Published in Int Arch Med on December 12, 2009
Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion. Heart Rhythm (2013) 1.04
The significance of the left atrial volume index in prediction of atrial fibrillation recurrence after electrical cardioversion. J Cardiovasc Thorac Res (2017) 0.75
Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study. BMC Cardiovasc Disord (2017) 0.75
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med (2002) 8.37
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med (2000) 4.27
Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc (2000) 3.59
Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol (2004) 3.50
Surgical treatment of atrial fibrillation; a systematic review. Eur J Cardiothorac Surg (2005) 3.06
Management of atrial fibrillation. N Engl J Med (1992) 2.95
Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation (1995) 2.88
Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation (1997) 2.52
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation (1990) 2.51
Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA (1992) 2.31
Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart (2004) 2.23
Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med (1999) 2.12
Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol (1991) 2.02
Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol (2004) 1.41
Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol (1989) 1.40
Cardioversion of atrial fibrillation in the elderly. ALKK-Study Group. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausaerzte. Am J Cardiol (1996) 1.33
Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med (1997) 1.29
Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol (2005) 1.11
Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol (2001) 1.11
Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol (1993) 1.11
Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion. Am J Cardiol (2006) 1.06
Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. Am J Card Imaging (1996) 0.99
Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide. Arch Intern Med (1995) 0.85
Does advanced age affect the immediate and long-term results of direct-current external cardioversion of atrial fibrillation? J Am Geriatr Soc (2002) 0.83
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Int J Clin Pract (2007) 0.81
Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study. Cardiology (2005) 0.79
Rate control vs. pulmonary vein isolation. Am J Geriatr Cardiol (2005) 0.79
Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation. Am J Cardiol (2004) 0.79
Radiofrequency ablation in the pulmonary veins for paroxysmal, drug-resistant atrial fibrillation. Dimens Crit Care Nurs (2004) 0.78
A clinical study of patients with and without recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation. Pacing Clin Electrophysiol (2005) 0.77
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med (2009) 12.44
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (2003) 11.88
Recommendations for chamber quantification. Eur J Echocardiogr (2006) 11.39
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Percutaneous repair or surgery for mitral regurgitation. N Engl J Med (2011) 5.78
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med (2014) 3.80
Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol (2009) 3.26
Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol (2004) 3.22
Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol (2012) 3.01
Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol (2003) 2.91
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol (2011) 2.84
Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2012) 2.78
Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol (2005) 2.56
Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke (2004) 2.37
Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation (2005) 2.36
Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol (2012) 2.31
Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation (2013) 2.24
The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest (2003) 2.10
Palliative care for patients with heart failure. JAMA (2004) 2.09
Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation (2011) 2.08
Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care (2006) 2.05
Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol (2011) 1.95
Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol (2005) 1.90
Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J Clin Invest (2006) 1.81
Clinical relevance of retrograde inferior vena cava or hepatic vein opacification during contrast-enhanced CT. AJR Am J Roentgenol (2004) 1.73
A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol (2013) 1.72
Assessment of systolic dyssynchrony for cardiac resynchronization therapy is not clinically useful. Circulation (2011) 1.67
Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices. J Cardiovasc Electrophysiol (2004) 1.63
4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol (2013) 1.62
Relationship between accurate auscultation of a clinically useful third heart sound and level of experience. Arch Intern Med (2006) 1.61
Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke (2005) 1.61
Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy. Circulation (2013) 1.58
The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. Am Heart J (2010) 1.53
ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics (2005) 1.46
ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. J Am Coll Cardiol (2003) 1.42
Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography. Am J Physiol Heart Circ Physiol (2005) 1.42
Osteoarthritis, exercise, and knee replacement. J Rheumatol (2012) 1.41
Is MRI the preferred method for evaluating right ventricular size and function in patients with congenital heart disease?: MRI is not the preferred method for evaluating right ventricular size and function in patients with congenital heart disease. Circ Cardiovasc Imaging (2014) 1.38
Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarction. Am J Physiol Heart Circ Physiol (2006) 1.33
Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events. BMC Fam Pract (2008) 1.32
Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg (2006) 1.32
Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation (2010) 1.31
Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation (2002) 1.30
Imaging biomarkers of aortic disease: increased growth rates with eccentric systolic flow. J Am Coll Cardiol (2012) 1.20
Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake. Circulation (2005) 1.15
Pulmonary dead space fraction and pulmonary artery systolic pressure as early predictors of clinical outcome in acute lung injury. Chest (2007) 1.10
High-sensitivity C-reactive protein and parameters of left ventricular dysfunction. J Card Fail (2006) 1.09
Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol (2005) 1.08
Mortality associated with adult congenital heart disease: Trends in the US population from 1979 to 2005. Am Heart J (2009) 1.08
Anomalous origin of the left coronary artery from the pulmonary artery: a case series and brief review. Congenit Heart Dis (2006) 1.06
The acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol (2011) 1.06
Surgical revision after percutaneous mitral repair with the MitraClip device. Ann Thorac Surg (2010) 1.05
Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Circ Heart Fail (2011) 1.05
Repeat transseptal catheterization after ablation for atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.05
The clinical pharmacology of intranasal l-methamphetamine. BMC Clin Pharmacol (2008) 1.04
Endovascular edge-to-edge mitral valve repair: short-term results in a porcine model. Circulation (2003) 1.04
Left ventricular pressure-volume relationship in conscious mice. Am J Physiol Heart Circ Physiol (2006) 1.02
Working group 2: How to encourage more women to choose a career in cardiology. J Am Coll Cardiol (2004) 1.01
Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation. Am J Cardiol (2008) 0.98
Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention (2009) 0.96
Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function. JAMA (2005) 0.95
New technique for measurement of left ventricular pressure in conscious mice. Am J Physiol Heart Circ Physiol (2003) 0.94
Regarding: a cohort study of systemic and local complications following implantation of testicular prostheses. Ann Epidemiol (2003) 0.94
Age and aneurysm position predict patterns of left ventricular dysfunction after subarachnoid hemorrhage. J Am Soc Echocardiogr (2005) 0.94
Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response. Circulation (2004) 0.94
Survey results: a decade of change in professional life in cardiology: a 2008 report of the ACC women in cardiology council. J Am Coll Cardiol (2008) 0.94
Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage. Neurocrit Care (2005) 0.93
Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol (2011) 0.92
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur Heart J (2011) 0.92
Closure of a para-valvular aortic leak: with the use of 2 AMPLATZER devices and real-time 2- and 3-dimensional transesophageal echocardiography. Tex Heart Inst J (2011) 0.92
Diagnostic characteristics of combining phonocardiographic third heart sound and systolic time intervals for the prediction of left ventricular dysfunction. J Card Fail (2007) 0.91
Post-stenotic dilation: evaluation of ascending aortic dilation with 4D flow MR imaging. Int J Cardiol (2011) 0.91
Congenital heart disease in the older adult: a scientific statement from the American Heart Association. Circulation (2015) 0.91
Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiogr (2007) 0.90
Epinephrine is required for normal cardiovascular responses to stress in the phenylethanolamine N-methyltransferase knockout mouse. Circulation (2007) 0.89
Pulmonary insufficiency is the nexus of late complications in tetralogy of Fallot. Curr Cardiol Rep (2007) 0.89
ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on clinical competence. J Am Soc Echocardiogr (2003) 0.89
Impaired regional left ventricular strain after repair of tetralogy of Fallot. J Magn Reson Imaging (2011) 0.88
EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg (2012) 0.88
Echocardiographic predictors of single versus dual MitraClip device implantation and long-term reduction of mitral regurgitation after percutaneous repair. Catheter Cardiovasc Interv (2013) 0.86
Association of the fourth heart sound with increased left ventricular end-diastolic stiffness. J Card Fail (2008) 0.83
Clinical factors and echocardiographic techniques related to the presence, size, and location of acoustic windows for leadless cardiac pacing. Europace (2011) 0.83
Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009. J Rheumatol (2013) 0.82
Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization. Med Care (2016) 0.82
Correlation between right ventricular indices and clinical improvement in epoprostenol treated pulmonary hypertension patients. Echocardiography (2005) 0.81
Isolated bundle branch block and left ventricular dysfunction. J Card Fail (2003) 0.81
Anticoagulation during pregnancy. Curr Womens Health Rep (2002) 0.81
Demonstration of coronary artery flow using transthoracic Doppler echocardiography. J Am Soc Echocardiogr (2004) 0.81
Harmonic imaging improves sensitivity at the expense of specificity in the detection of patent foramen ovale. Echocardiography (2004) 0.80
Clinical significance of elevated B-type natriuretic peptide in patients with acute lung injury with or without right ventricular dilatation: an observational cohort study. Ann Intensive Care (2011) 0.80